As Summit Therapeutics’ Chinese partner prepares to reveal data for a key trial at ASCO, analysts consider the impact on rivals Merck, Bristol Myers Squibb and BioNTech.
Drug companies have wagered billions on bispecific antibody drugs ever since one of them, ivonescimab, a PD-1 and vascular ...
Patients with previously untreated advanced squamous non-small-cell lung cancer lived significantly longer without their ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PARK CITY, Utah — In this Healio Video Perspective from ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...
Real-world diabetic macular edema care lags trials as fewer VEGF injections and step therapy limit outcomes. Persistent ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Some patients are suboptimal responders to anti-VEGF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results